Document Detail


IRF4 silencing inhibits Hodgkin lymphoma cell proliferation, survival and CCL5 secretion.
MedLine Citation:
PMID:  21114485     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Interferon regulatory factor 4 (IRF4) expression is detected in many lymphoid and myeloid malignancies, and may be a promising therapeutic target. IRF4 is strongly expressed in classical Hodgkin lymphoma (cHL) and its expression is up-regulated by CD40L and down-regulated by both anti-proliferative and pro-apoptotic stimuli. This study analysed the effects of IRF4 silencing in a panel of HL-derived cell lines. We demonstrated that IRF4 down-modulation determined a remarkable decrease of both cell number and clonogenic growth in L-1236, L-428, KM-H2 and HDLM-2 cells, but not in IRF4-negative L-540 cells. IRF4 silencing induced apoptosis, as evaluated by caspase-3 activation and Annexin-V staining and up-regulation of the pro-apoptotic molecule Bax. CD40 engagement by both soluble and membrane bound-CD40L almost totally reduced IRF4 down-modulation and growth inhibition by IRF4 silencing in both L-1236 and L-428 cells. Finally, IRF4 silencing decreased CCL5 secretion in all HL cell lines tested and CCL17 in KM-H2 cells. Taken together, our results demonstrated that IRF4 down-modulation by IRF4 silencing was reversed by CD40 engagement, inhibited HL cells proliferation, induced apoptosis and decreased CCL5 secretion, thus suggesting that IRF4 may be involved in HL pathobiology.
Authors:
Donatella Aldinucci; Marta Celegato; Cinzia Borghese; Alfonso Colombatti; Antonino Carbone
Related Documents :
2116225 - Use of intracellular h3 messenger rna as a marker to determine the proliferation patter...
3943135 - Vincristine sulfate-induced cell transformation, mitotic inhibition and aneuploidy in c...
22688405 - Clonally expanded mitochondrial dna deletions within the choroid plexus in multiple scl...
20093405 - Htlv-i tax-dependent and -independent events associated with immortalization of human p...
7758245 - Fusome asymmetry and oocyte determination in drosophila.
21826705 - Erα17p, an erα p(295) -t(311) fragment, modifies the migration of breast cancer cells...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-11-28
Journal Detail:
Title:  British journal of haematology     Volume:  152     ISSN:  1365-2141     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  182-90     Citation Subset:  IM    
Copyright Information:
© 2010 Blackwell Publishing Ltd.
Affiliation:
Centro di Riferimento Oncologico, IRCCS-National Cancer Institute, Aviano, Italy. daldinucci@cro.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  PR-924, a selective inhibitor of the immunoproteasome subunit LMP-7, blocks multiple myeloma cell gr...
Next Document:  Perceiving cancer-risks and heredity-likelihood in genetic-counseling: how counselees recall and int...